Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00358423 · ClinicalTrials.gov registry record · Phase 1
The Effect of Macugen in Patients With Chronic, Post-Operative Cystoid Macular Edema
A Phase 1 study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT00358423: Clinical Trial Phase 1 study, sponsored by Johns Hopkins University.
NCT00358423 is a Phase 1 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00358423, a Phase 1 study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
This research is being done to look at the effects of an experimental drug called pegaptanib (also called Macugen) for the treatment of swelling in the retina (the light sensitive tissue in the back of the eye) that can occur after cataract surgery. Swelling in the retina can lead to blurry vision. The only treatment available for this condition is eye drops that decrease swelling in the back of the eye, but eye drops may not decrease the swelling in everyone. We want to see if pegaptanib can decrease swelling in the retina and improve vision in patients with swelling after cataract surgery.
Interventions
- DRUG Control
- DRUG Pegaptanib Sodium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2006-07 |
| Est. Completion | 2007-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00358423
The ClinicalTrials.gov registry entry for NCT00358423 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT00358423 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00358423 about?
NCT00358423 is a clinical study titled "The Effect of Macugen in Patients With Chronic, Post-Operative Cystoid Macular Edema". This research is being done to look at the effects of an experimental drug called pegaptanib (also called Macugen) for the treatment of swelling in the retina (the light sensitive tissue in the back of the eye) that can occur after cataract surgery. Swelling in the retina can lead to blurry vision. ...
What is the current status of trial NCT00358423?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2006-07. Estimated completion is 2007-02.
What interventions are being tested in trial NCT00358423?
The interventions under investigation include: Control (DRUG), Pegaptanib Sodium (DRUG).
Who is sponsoring clinical trial NCT00358423?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.